BioCorRx (BICX) Retained Earnings (2010 - 2026)

BioCorRx has reported Retained Earnings for 17 years, with the latest figure at -$87.5 million in Q1 2026.

• Quarterly Retained Earnings fell 220.9% year-over-year to -$87.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$87.5 million (down 220.9% YoY) and the FY2025 annual result came in at $75.3 million, up 6.1% from the prior year.
• Retained Earnings declined to -$87.5 million in Q1 2026 per BICX's latest filing, from $75.3 million in the prior quarter.
• Over five years, Retained Earnings peaked at $75.3 million in Q4 2025 and troughed at -$87.5 million in Q1 2026.
• A 5-year average of $8.5 million and a median of $66.8 million in 2023 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2023 and 2025: Retained Earnings surged 193.53% in 2023, then tumbled 224.43% in 2025.
• Over 5 years, Retained Earnings stood at -$74.3 million in 2022, then retreated by 5.07% to -$78.1 million in 2023, then surged by 190.85% to $71.0 million in 2024, then rose by 6.1% to $75.3 million in 2025, then slumped by 216.21% to -$87.5 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$87.5 million, $75.3 million, and -$87.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.